Filing Details
- Accession Number:
- 0001415889-25-018187
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-06-25 16:30:05
- Reporting Period:
- 2025-06-23
- Filing Date:
- 2025-06-25
- Accepted Time:
- 2025-06-25 16:30:05
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1727196 | Scholar Rock Holding Corp | SRRK | Biological Products, (No Disgnostic Substances) (2836) | 823750435 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1740266 | S. Jeffrey Flier | 301 Binney Street Cambridge MA 02142 | No | No | No | No |
Transaction Summary
| Sold: | 31,452 shares | Avg. Price: $32.58 | Total Value: $1,024,721.98 |
| Number of Shares After Transactions: | 11,136 shares | ||
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2025-06-23 | 20,316 | $21.62 | 44,386 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2025-06-23 | 17,550 | $32.16 | 26,836 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-06-23 | 2,766 | $32.74 | 24,070 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2025-06-23 | 11,136 | $33.21 | 11,136 | No | 4 | S | Indirect | By trust |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Indirect | By trust |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2025-06-23 | 20,316 | $0.00 | 20,316 | $21.62 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2028-06-22 | No | 4 | M | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted on February 27, 2025.
- Consists of 36,754 shares of common stock and 7,632 restricted stock units (RSUs).
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.645 to $32.609, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- Consists of 19,204 shares of common stock and 7,632 RSUs.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.640 to $32.830, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- Consists of 16,438 shares of common stock and 7,632 RSUs.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $32.830 to $33.790, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
- Represents shares owned directly by The Jeffrey S. Flier Family Trust - 2014, for which the Reporting Person's spouse, Eleftheria Maratos-Flier, and Samuel C. Sichko are trustees. The Reporting Person disclaims Section 16 beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for Section 16 or any other purpose.
- No shares remain unvested under this stock option.
Billionaire Hedge Funds
